Holen Sie sich die Stockscreener-App
29.23
1.58%
-0.47
Finanzdaten der Caris Life Sciences Inc-Aktie (CAI)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
21.99%
263.71
|
216.17 | 292.89 | 216.83 | 181.40 |
| Research and Development |
3.33%
32.36
|
31.32 | 31.84 | 21.62 | 25.05 |
| Costs And Expenses |
12.28%
236.79
|
210.89 | 204.47 | 184.19 | 199.39 |
| Operating Income/Loss |
409.77%
26.93
|
5.282 | 88.41 | 32.64 | -17.99 |
| Nonoperating Income/Loss |
364.73%
-27.54
|
-5.926 | -6.454 | -8.317 | -53.80 |
| Income/Loss From Continuing Operations Before Tax |
4.66%
-0.614
|
-0.644 | 81.96 | 24.32 | -71.79 |
| Income Tax Expense/Benefit |
117.16%
0.023
|
-0.134 | - | - | - |
Net Income/Loss
|
24.90%
-0.637
|
-0.51 | 81.96 | 24.32 | -71.79 |
| Basic Average Shares |
0.12%
282.89
|
282.56 | - | 282.10 | 64.92 |
| Diluted Average Shares |
0.12%
282.89
|
282.56 | - | 297.21 | 64.92 |
| Basic Earnings Per Share |
-
|
- | - | 0.09 | -7.97 |
| Diluted Earnings Per Share |
-
|
- | - | 0.08 | -7.97 |
1.30%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):